Table 2. Relative risk (RR) of COVID-19 related hospitalization/death.
| %(n) events | RR | 95% CI | Adjusted RR | 95% CI | ||
|---|---|---|---|---|---|---|
| Age in years | 18–29 | 1.5(45) | 1 | 1 | ||
| 30–39 | 2.4(63) | 1.62 | 1.1–2.37 | 1.77 | 1.21–2.6 | |
| 40–49 | 3.3(71) | 2.18 | 1.5–3.17 | 2.56 | 1.76–3.72 | |
| 50–59 | 5.7(84) | 3.78 | 2.63–5.43 | 4.93 | 3.41–7.1 | |
| 60+ | 16.9(160) | 11.31 | 8.13–15.75 | 12.84 | 9.1–18.11 | |
| Gender | Female | 4(221) | 1 | 1 | ||
| Male | 4.4(202) | 1.1 | 0.91–1.34 | 1.1 | 0.9–1.33 | |
| Vaccine type | no vaccine | 6.4(237) | 1 | 1 | ||
| Covishield full | 3.9(51) | 0.6 | 0.45–0.82 | 0.3 | 0.22–0.42 | |
| Covishield partial | 9(52) | 1.39 | 1.03–1.88 | 0.71 | 0.51–0.99 | |
| Sinopharm full | 1.7(65) | 0.26 | 0.2–0.34 | 0.29 | 0.22–0.38 | |
| Sinopharm partial | 2.5(18) | 0.4 | 0.25–0.64 | 0.39 | 0.24–0.64 | |
| Month of infection | January/February 2021 | 6.2(57) | 1 | 1 | ||
| March 2021 | 5.2(50) | 0.85 | 0.58–1.24 | 0.74 | 0.5–1.1 | |
| April 2021 | 5.5(88) | 0.88 | 0.63–1.23 | 1.09 | 0.77–1.53 | |
| May 2021 | 3(117) | 0.48 | 0.35–0.66 | 0.71 | 0.51–0.99 | |
| June 2021 | 3.9(111) | 0.63 | 0.46–0.87 | 0.9 | 0.64–1.27 |